|4Apr 18, 8:02 AM ET

Ryan Jane 4

4 · Neuphoria Therapeutics Inc. · Filed Apr 18, 2025

Insider Transaction Report

Form 4
Period: 2025-04-16
Ryan Jane
Director
Transactions
  • Award

    Restricted Stock Units

    2025-04-16+6,7837,013 total
    Common Stock (6,783 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
  • [F2]Subject to the Reporting Person's continuous service to the Company through the day prior to the Company' next annual shareholder meeting (which is expected to be no later than November 30, 2025), the RSUs shall fully vest at 5:01 PM EST on the day prior to the Company's next annual shareholder meeting.

Documents

1 file
  • 4
    ownership.xmlPrimary

    OWNERSHIP DOCUMENT